Guardian Pharmacy Services, Inc.

GRDNReported to SECin USCIK 0001802255Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 34. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 34
Form 4 lines at Guardian Pharmacy Services, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Mudd William FranklinSee RemarksOption exercise—38,282 sharesSep 28, 2026Mudd William FranklinSee Remarks—Exercise · Sep 28Option exercise38,282Sep 28, 2026
Mudd William FranklinSee RemarksOption exercise—38,282 sharesSep 28, 2026Mudd William FranklinSee Remarks—Exercise · Sep 28Option exercise38,282Sep 28, 2026
Weir RobertSee RemarksOption exercise—23,450 sharesSep 28, 2026Weir RobertSee Remarks—Exercise · Sep 28Option exercise23,450Sep 28, 2026
Weir RobertSee RemarksOption exercise—23,450 sharesSep 28, 2026Weir RobertSee Remarks—Exercise · Sep 28Option exercise23,450Sep 28, 2026
Ackerman John—Option exercise—471,057 sharesSep 28, 2026Ackerman John—Exercise · Sep 28Option exercise471,057Sep 28, 2026